Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2009-11-25
pubmed:abstractText
Microplasmin is a recombinant truncated form of human plasmin. It has demonstrated efficacy in experimental animal models of stroke and tolerability in healthy volunteers. We tested the tolerability of microplasmin in patients with acute ischemic stroke.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1524-4628
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3789-95
pubmed:meshHeading
pubmed-meshheading:19834019-Acute Disease, pubmed-meshheading:19834019-Aged, pubmed-meshheading:19834019-Aged, 80 and over, pubmed-meshheading:19834019-Brain Ischemia, pubmed-meshheading:19834019-Cerebral Revascularization, pubmed-meshheading:19834019-Dose-Response Relationship, Drug, pubmed-meshheading:19834019-Female, pubmed-meshheading:19834019-Fibrinolysin, pubmed-meshheading:19834019-Fibrinolytic Agents, pubmed-meshheading:19834019-Humans, pubmed-meshheading:19834019-Injections, Intravenous, pubmed-meshheading:19834019-Magnetic Resonance Imaging, pubmed-meshheading:19834019-Male, pubmed-meshheading:19834019-Middle Aged, pubmed-meshheading:19834019-Peptide Fragments, pubmed-meshheading:19834019-Placebos, pubmed-meshheading:19834019-Stroke, pubmed-meshheading:19834019-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Randomized, placebo-controlled, dose-ranging clinical trial of intravenous microplasmin in patients with acute ischemic stroke.
pubmed:affiliation
Department of Neurology, University Hospitals Leuven, Leuven, Belgium. vincent.thijs@uz.kuleuven.ac.be
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Multicenter Study, Clinical Trial, Phase II